Park Min-su, the newly appointed 2nd Vice Minister of Health and Welfare.

Park Min-su, the newly appointed 2nd Vice Minister of Health and Welfare.

View original image


[Asia Economy Reporter Kim Young-won] On the 24th, Park Min-su, the 2nd Vice Minister of Health and Welfare, who took office, expressed his ambition to "catch both rabbits of creating better health and welfare services and a robust social safety net, and through this, ensuring a virtuous cycle between welfare and the economy."


In his inaugural speech, Vice Minister Park said, "About 180 trillion won in national finances and health insurance finances are being invested in health and welfare sectors such as old-age income security, childcare services, and health insurance, and this scale will grow even larger in the future."


He stated, "We will guarantee essential medical care for all citizens," adding, "We plan to concentrate related resources not only in severe and emergency fields but also in pediatric and maternal sectors, which require full support due to a sharp decline in demand."


Vice Minister Park continued, "We will manage and improve the health care system to ensure its sustainability," and said, "While maintaining the health insurance benefits that citizens appropriately use, we will sufficiently supplement and improve inappropriate parts to manage finances efficiently."


Regarding COVID-19, he said, "There have been over 20,000 confirmed cases for four consecutive weeks recently, and we must also prepare for the simultaneous outbreak with the upcoming winter flu," adding, "We will make every effort to organize quarantine and medical systems to protect both the daily lives of citizens and the safety of high-risk groups."



Finally, as the 2nd Vice Minister overseeing the health and medical fields, he also pledged to create an innovative ecosystem for the health industry. He said, "We will expand investments through public-private cooperation, such as establishing a global new drug development mega fund and expanding vaccine and therapeutic research and development, ensuring that the added value created exceeds the investment amount and is returned to the economy and society."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing